Research, VIEWS AND ANALYSIS

Pharma R&D Annual Review 2023

April 20, 2023

Pharma R&D Annual
Welcome to Pharmaprojects’ 2023 review of trends in pharmaceutical R&D. For over 30 years now, I’ve been taking an annual look at the evolution of pharma R&D, and in this article, I’llexamine the state of play at the start of 2023.

Spotlight

Asian Pharmaceuticals Private LTD

Asian Pharmaceuticals Pvt. Ltd. is a renowned manufacturer of a broad range of prescription and non-prescription drugs in Nepal. Established in 2055 B.S. (1998 AD), Asian Pharmaceuticals Pvt. Ltd. is founded on a deep sense of National Pride and the conviction to make a contribution to our country's self-reliance in the field of Pharmaceutical formulations

OTHER WHITEPAPERS
news image

Best practices in viral vector analytical characterization

whitePaper | December 13, 2022

Viral vectors are a critical part of the advanced therapies supply chain as they are used to introduce the gene of interest, whether that’s into a cell intended for therapeutic gene transfer or for direct viral-mediated gene transfer into the patient.

Read More
news image

Benefits of Semantic Enrichment Across the Drug Development Pipeline

whitePaper | January 24, 2022

Semantics is the process of assigning meaning to words and is a vital step in making unstructured scientific content machine readable, contextualizing otherwise unstructured information. It unlocks a host of benefits to search and analytics which are outlined below in the context of use cases relevant to drug discovery.

Read More
news image

Overcoming technical challenges in cell-based high throughput screens

whitePaper | November 11, 2022

Tremendous technological advancements in automated biotechnology and combinatorial chemistry have led to the widespread implementation of high throughput screening (HTS) for drug discovery since the early 1990s.

Read More
news image

How Specialty Pharmacy Can Drive Better Outcomesin Multiple Sclerosis

whitePaper | June 14, 2022

Multiple sclerosis (MS) is a chronic, inflammatory disease of the central nervous system. Characterized by demyelination and neurodegeneration that affects the communication between the brain and other parts of the body, MS leads to physical and cognitive disability.

Read More
news image

BUILDING A TOMORROW-READY LAB

whitePaper | September 8, 2022

Charles Darwin famously said on survival, "It is not the strongest of the species that survives, nor the most intelligent; it is the one most adaptable to change." Resilience has become an essential message in today's post-covid, next-normal world.

Read More
news image

High Pressure Homogenizer for Nano-formulation

whitePaper | December 16, 2022

NanoGenizer, a lab-scale microfluidic high pressure homogenizer, utilizes interaction high-pressure microfluidic jet technology, and it is equipped with highly modular power and processing units.

Read More

Spotlight

Asian Pharmaceuticals Private LTD

Asian Pharmaceuticals Pvt. Ltd. is a renowned manufacturer of a broad range of prescription and non-prescription drugs in Nepal. Established in 2055 B.S. (1998 AD), Asian Pharmaceuticals Pvt. Ltd. is founded on a deep sense of National Pride and the conviction to make a contribution to our country's self-reliance in the field of Pharmaceutical formulations

Events